17 - 21 June 2017
Helsinki, Finland

Industry Programme

Disclosure of Transfers of Value

EAACI publishes the conditions and the scope of the support provided by EFPIA member companies to EAACI on a voluntary basis. The publication will be carried out before and during the execution of the EAACI Congress.

For the industry partners mentioned below, we are herewith informing about their overall support within the framework of the EAACI Congress 2017.

Novartis Pharma AG Founder Sponsorship: 232.500 €
Exhibition: 32.500 €
Sponsorship: 6.000 €
Allergopharma GmbH & Co. KG Founder Sponsorship: 175.700 €
Other Items: 1.900 €
Allergy Therapeutics plc. Founder Sponsorship: 184.700 €
Exhibition: 34.000 €
Sponsorship: 45.000 €
DIATER Exhibition: 13.000 €
PHILIPS Exhibition: 15.600 €
Sponsorship: 5.000 €
Nutricia Exhibition: 9.750 €
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback